Semaglutide Therapy for Alcohol Reduction (STAR)

Abroad (travel likely)RecruitingPHASE2

Conditions

Addiction · Alcohol Use Disorder

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Institute on Drug Abuse, Baltimore, Maryland, United States
Contact: Study coordinator (Masoumeh Dejman) · masoumeh.dejman@nih.gov · 240-987-8983
Contact: Study coordinator (Lorenzo Leggio, M.D.) · lorenzo.leggio@nih.gov · (240) 478-1503

Study leads

Lorenzo Leggio, M.D.
Principal Investigator
National Institute on Drug Abuse (NIDA)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool

Alcohol Use Disorder · Addiction · Alcohol Withdrawal

Abroad (travel likely)Recruiting

Montpellier, France

Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community

Substance Use Disorder (SUD) · Alcohol Use Disorder (AUD) · Nicotine Addiction

Abroad (travel likely)Recruiting

Fehring, Austria · Graz, Austria

Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)

Addiction, Substance · Alcohol Use Disorder · Alcohol Dependence

Abroad (travel likely)Recruiting

Étampes, France

Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment and Reduction of Heavy Drinking in Individuals With of Alcohol Use Disorder (AUD)

Alcohol Use Disorder · Alcoholism · Alcohol Abuse

IsraelRecruiting

Tuscaloosa, United States · La Jolla, United States